221 related articles for article (PubMed ID: 9628876)
1. Two distinct nuclear receptor interaction domains in NSD1, a novel SET protein that exhibits characteristics of both corepressors and coactivators.
Huang N; vom Baur E; Garnier JM; Lerouge T; Vonesch JL; Lutz Y; Chambon P; Losson R
EMBO J; 1998 Jun; 17(12):3398-412. PubMed ID: 9628876
[TBL] [Abstract][Full Text] [Related]
2. NRIF3 is a novel coactivator mediating functional specificity of nuclear hormone receptors.
Li D; Desai-Yajnik V; Lo E; Schapira M; Abagyan R; Samuels HH
Mol Cell Biol; 1999 Oct; 19(10):7191-202. PubMed ID: 10490654
[TBL] [Abstract][Full Text] [Related]
3. The orphan nuclear receptor SHP utilizes conserved LXXLL-related motifs for interactions with ligand-activated estrogen receptors.
Johansson L; Båvner A; Thomsen JS; Färnegårdh M; Gustafsson JA; Treuter E
Mol Cell Biol; 2000 Feb; 20(4):1124-33. PubMed ID: 10648597
[TBL] [Abstract][Full Text] [Related]
4. Molecular determinants of nuclear receptor-corepressor interaction.
Perissi V; Staszewski LM; McInerney EM; Kurokawa R; Krones A; Rose DW; Lambert MH; Milburn MV; Glass CK; Rosenfeld MG
Genes Dev; 1999 Dec; 13(24):3198-208. PubMed ID: 10617569
[TBL] [Abstract][Full Text] [Related]
5. Specific structural motifs determine TRAP220 interactions with nuclear hormone receptors.
Ren Y; Behre E; Ren Z; Zhang J; Wang Q; Fondell JD
Mol Cell Biol; 2000 Aug; 20(15):5433-46. PubMed ID: 10891484
[TBL] [Abstract][Full Text] [Related]
6. Human TAF(II)55 interacts with the vitamin D(3) and thyroid hormone receptors and with derivatives of the retinoid X receptor that have altered transactivation properties.
Lavigne AC; Mengus G; Gangloff YG; Wurtz JM; Davidson I
Mol Cell Biol; 1999 Aug; 19(8):5486-94. PubMed ID: 10409738
[TBL] [Abstract][Full Text] [Related]
7. Mechanistic principles in NR box-dependent interaction between nuclear hormone receptors and the coactivator TIF2.
Leers J; Treuter E; Gustafsson JA
Mol Cell Biol; 1998 Oct; 18(10):6001-13. PubMed ID: 9742117
[TBL] [Abstract][Full Text] [Related]
8. Mechanism of corepressor binding and release from nuclear hormone receptors.
Nagy L; Kao HY; Love JD; Li C; Banayo E; Gooch JT; Krishna V; Chatterjee K; Evans RM; Schwabe JW
Genes Dev; 1999 Dec; 13(24):3209-16. PubMed ID: 10617570
[TBL] [Abstract][Full Text] [Related]
9. Alien, a highly conserved protein with characteristics of a corepressor for members of the nuclear hormone receptor superfamily.
Dressel U; Thormeyer D; Altincicek B; Paululat A; Eggert M; Schneider S; Tenbaum SP; Renkawitz R; Baniahmad A
Mol Cell Biol; 1999 May; 19(5):3383-94. PubMed ID: 10207062
[TBL] [Abstract][Full Text] [Related]
10. ERAP140, a conserved tissue-specific nuclear receptor coactivator.
Shao W; Halachmi S; Brown M
Mol Cell Biol; 2002 May; 22(10):3358-72. PubMed ID: 11971969
[TBL] [Abstract][Full Text] [Related]
11. NRC-interacting factor 1 is a novel cotransducer that interacts with and regulates the activity of the nuclear hormone receptor coactivator NRC.
Mahajan MA; Murray A; Samuels HH
Mol Cell Biol; 2002 Oct; 22(19):6883-94. PubMed ID: 12215545
[TBL] [Abstract][Full Text] [Related]
12. Structure and specificity of nuclear receptor-coactivator interactions.
Darimont BD; Wagner RL; Apriletti JW; Stallcup MR; Kushner PJ; Baxter JD; Fletterick RJ; Yamamoto KR
Genes Dev; 1998 Nov; 12(21):3343-56. PubMed ID: 9808622
[TBL] [Abstract][Full Text] [Related]
13. Molecular dynamics simulations reveal multiple pathways of ligand dissociation from thyroid hormone receptors.
Martínez L; Sonoda MT; Webb P; Baxter JD; Skaf MS; Polikarpov I
Biophys J; 2005 Sep; 89(3):2011-23. PubMed ID: 15980170
[TBL] [Abstract][Full Text] [Related]
14. Structural and functional analysis of the DEAF-1 and BS69 MYND domains.
Kateb F; Perrin H; Tripsianes K; Zou P; Spadaccini R; Bottomley M; Franzmann TM; Buchner J; Ansieau S; Sattler M
PLoS One; 2013; 8(1):e54715. PubMed ID: 23372760
[TBL] [Abstract][Full Text] [Related]
15. ADA3-containing complexes associate with estrogen receptor alpha.
Benecke A; Gaudon C; Garnier JM; vom Baur E; Chambon P; Losson R
Nucleic Acids Res; 2002 Jun; 30(11):2508-14. PubMed ID: 12034840
[TBL] [Abstract][Full Text] [Related]
16. Retinoic acid actions through mammalian nuclear receptors.
Huang P; Chandra V; Rastinejad F
Chem Rev; 2014 Jan; 114(1):233-54. PubMed ID: 24308533
[No Abstract] [Full Text] [Related]
17. UBR5 forms ligand-dependent complexes on chromatin to regulate nuclear hormone receptor stability.
Tsai JM; Aguirre JD; Li YD; Brown J; Focht V; Kater L; Kempf G; Sandoval B; Schmitt S; Rutter JC; Galli P; Sandate CR; Cutler JA; Zou C; Donovan KA; Lumpkin RJ; Cavadini S; Park PMC; Sievers Q; Hatton C; Ener E; Regalado BD; Sperling MT; Słabicki M; Kim J; Zon R; Zhang Z; Miller PG; Belizaire R; Sperling AS; Fischer ES; Irizarry R; Armstrong SA; Thomä NH; Ebert BL
Mol Cell; 2023 Aug; 83(15):2753-2767.e10. PubMed ID: 37478846
[TBL] [Abstract][Full Text] [Related]
18. Covalent ligands of nuclear receptors.
Rajan S; Yoon HS
Eur J Med Chem; 2023 Dec; 261():115869. PubMed ID: 37857142
[TBL] [Abstract][Full Text] [Related]
19. An emerging link between LIM domain proteins and nuclear receptors.
Sala S; Ampe C
Cell Mol Life Sci; 2018 Jun; 75(11):1959-1971. PubMed ID: 29428964
[TBL] [Abstract][Full Text] [Related]
20. Shared and divergent contribution of vitamin A and oxytocin to the aetiology of autism spectrum disorder.
Wang T; Liu L; Fan T; Xia K; Sun Z
Comput Struct Biotechnol J; 2023; 21():3109-3123. PubMed ID: 38213898
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
